http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104922599-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-9066 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-618 |
| filingDate | 2015-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104922599-B |
| titleOfInvention | It is a kind of to be used to improve Chinese medicine composition of hemorrhagic cystitis and preparation method thereof caused by using treated with gefitinib cancer of pancreas |
| abstract | A kind of to be used to improve Chinese medicine composition of hemorrhagic cystitis and preparation method thereof caused by using treated with gefitinib cancer of pancreas, it is related to a kind of for improving Chinese medicine composition of hemorrhagic cystitis and preparation method thereof caused by using treated with gefitinib cancer of pancreas.The present invention provides a kind of for improving Chinese medicine composition of hemorrhagic cystitis and preparation method thereof caused by using treated with gefitinib cancer of pancreas, the present composition is made of mixture A, mixture B, Eupolyphaga protein medicinal extract and calcined oyster shell cream, and preparation method is：Raw material is weighed, mixture A is prepared, prepares mixture B, weighs Eupolyphaga protein medicinal extract and calcined oyster shell cream, that is, is completed.Traditional Chinese medicine compound composition provided by the invention can be used for improving the hemorrhagic cystitis caused by using treated with gefitinib cancer of pancreas, and preparation process design is reasonable, and extract active constituent content is high, and pharmacological activity is stronger, and impurity is few.The present invention is applied to medical domain. |
| priorityDate | 2015-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 85.